Roberto Scatena - Concepedia

Author

Roberto Scatena

Università Cattolica del Sacro Cuore ORCID

Also Known As

Enns,Gregory M. Enns, Keijer, J., R SCATENA, R Scatena, R. SCATENA, R. Scatena, Roberto Scatena, Sazanov, Leonid A, Scatena, Roberto, Schlattner, Uwe

Publications

3.7K

Citations

H-Index

Concepts

All Affiliations

Università Cattolica del Sacro Cuore University of Messina Sapienza University of Rome University of Rome Tor Vergata University of Siena

About

Roberto Scatena is an author at Università Cattolica del Sacro Cuore specializing in medicine, biochemistry, and physiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	23	730
2	Natural Sciences	8	8	246
3	Health Sciences	3	3	44
4	Education	1	1	31
5	Public Health	1	1	14

Roberto Scatena

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
Immunological Role of IgG Subclasses Cecilia Napodano, MariaPaola Marino, Annunziata Stefanile, Immunological Investigations ImmunodeficienciesImmunologyPathologyAntigen ProcessingImmunotherapy	2020	88
Mitochondrial respiratory chain dysfunction, a non-receptor-mediated effect of synthetic PPAR-ligands: biochemical and pharmacological implications Roberto Scatena, Patrizia Bottoni, Giuseppe Martorana, Biochemical and Biophysical Research Communications Molecular PharmacologyNon-receptor-mediated EffectMitochondrial FunctionBiochemistryMedicine	2004	75
The multikinase inhibitor Sorafenib enhances glycolysis and synergizes with glycolysis blockade for cancer cell killing Valentina Tesori, A.C. Piscaglia, Daniela Samengo, Scientific Reports	2015	75
3-(4-Aroyl-1-methyl-1<i>H</i>-2-pyrrolyl)-<i>N</i>-hydroxy-2-propenamides as a New Class of Synthetic Histone Deacetylase Inhibitors. 2. Effect of Pyrrole-C<sub>2</sub> and/or -C<sub>4</sub> Substitutions on Biological Activity Antonello Mai, Silvio Massa, Ilaria Cerbara, Journal of Medicinal Chemistry Chemoprevention StrategyPharmacotherapyChemical BiologyChemical DerivativePharmaceutical Chemistry	2004	57
Glycated human hemoglobin (HbA1c): functional characteristics and molecular modeling studies Maria Cristina De Rosa, Maria Teresa Sanna, Irene Messana, Biophysical Chemistry BiochemistryHeme HomeostasisPhysiologyGlycobiologyHuman Hemoglobin	1998	55
Binding Mode Analysis of 3-(4-Benzoyl-1-methyl-1<i>H</i>-2-pyrrolyl)-<i>N</i>-hydroxy-2-propenamide: A New Synthetic Histone Deacetylase Inhibitor Inducing Histone Hyperacetylation, Growth Inhibition, and Terminal Cell Differentiation Antonello Mai, Silvio Massa, Rino Ragno, Journal of Medicinal Chemistry Histone ModificationsHdac InhibitorsEpigenetic ChangeChemical BiologyEnzymatic Modification	2002	51
3-(4-Aroyl-1-methyl-1<i>H</i>-pyrrol-2-yl)-<i>N</i>-hydroxy-2-propenamides as a New Class of Synthetic Histone Deacetylase Inhibitors. 3. Discovery of Novel Lead Compounds through Structure-Based Drug Design and Docking Studies<sup>,</sup> Rino Ragno, Antonello Mai, Silvio Massa, Journal of Medicinal Chemistry	2004	49
Exploring the connection unit in the HDAC inhibitor pharmacophore model: Novel uracil-based hydroxamates Antonello Mai, Silvio Massa, Dante Rotili, Bioorganic & Medicinal Chemistry Letters BiochemistryMedicineNatural SciencesRational Drug DesignConnection Unit	2005	47
Mitochondria, PPARs, and Cancer: Is Receptor‐Independent Action of PPAR Agonists a Key? Roberto Scatena, Patrizia Bottoni, Bruno Giardina PPAR Research	2008	44
Bezafibrate Induces a Mitochondrial Derangement in Human Cell Lines: A PPAR-Independent Mechanism for a Peroxisome Proliferator Roberto Scatena, Patrizia Bottoni, Federica Vincenzoni, Chemical Research in Toxicology	2003	43

Page 1